Back to MNPR

UBS Group AG → MNPR

UBS Group AG MNPR Position History

Monopar Therapeutics Inc. • Healthcare

Quarters held
10
Latest value
$40K
Q3 2026
Peak value
$6.8M
First seen
Q3 2025

Dollar value over time

Show data table
PeriodPosition value
Q3 2025$623K
Q3 2025$10K
Q3 2025$18K
Q4 2025$276K
Q4 2025$1K
Q1 2026$2.2M
Q2 2026$2.5M
Q2 2026$11K
Q3 2026$6.8M
Q3 2026$40K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$40K497——
Q3 2026$6.8M84.8K——
Q2 2026$11K117——
Q2 2026$2.5M27.1K——
Q1 2026$2.2M39.4K——
Q4 2025$1K16——
Q4 2025$276K4.2K——
Q3 2025$18K226——
Q3 2025$10K118——
Q3 2025$623K7.6K——

Other funds holding MNPR

Other UBS Group AG positions

MSFT

MICROSOFT CORP

$8.1B
AAPL

APPLE INC

$7.8B
NVDA

NVIDIA CORPORATION

$7.8B
AAPL

APPLE INC

$7.7B
NVDA

NVIDIA CORPORATION

$7.7B
MSFT

MICROSOFT CORP

$7.6B
MSFT

MICROSOFT CORP

$7.4B
NVDA

NVIDIA CORPORATION

$7.3B